For researchers submitting trial data to ClinicalTrials.gov, the Adverse Events module is one of four mandatory results sections. It requires reporting in three primary categories: All-Cause Mortality: A table tracking all deaths that occurred during the study, regardless of cause. Serious Adverse Events (SAEs): A tabular summary of events resulting in death, life-threatening conditions, hospitalization, or significant disability. Other Adverse Events: A table for non-serious events that exceed a specific frequency threshold, such as 5% within any study arm.
Adverse Events Module path is as follows:
Study -> Results Section -> Adverse Events Module -> Event Groups
Study -> Results Section -> Adverse Events Module -> Serious Events
Study -> Results Section -> Adverse Events Module -> Other Events
| Title | Description | Deaths # Affected | Deaths # At Risk | Serious # Affected | Serious # At Risk | Other # Affected | Other # At Risk | View |
|---|---|---|---|---|---|---|---|---|
| NexoBrid Gel | NexoBrid Gel is applied to the burn wound at a dose of 2 g NexoBrid sterile powder mixed with 20g sterile Gel Vehicle per 1% of TBSA (\~ surface of an adult palm) for four hours. NexoBrid | 2 | None | 9 | 77 | 49 | 77 | View |
| Gel Vehicle | Gel Vehicle is applied to the burn wound at a dose of 20 g sterile Gel per 1% of TBSA (\~ surface of an adult palm) for four hours. Gel Vehicle | 0 | None | 3 | 24 | 16 | 24 | View |
| Standard of Care (SOC) | Subjects in the SOC group may be treated with a combination of surgical and non-surgical eschar removal procedures, according to the investigator's judgment. Standard of Care (SOC) | 0 | None | 9 | 68 | 39 | 68 | View |
| Term | Type | Organ System | Vocab | View |
|---|---|---|---|---|
| Atrial Septal Defect | SYSTEMATIC_ASSESSMENT | Congenital, familial and genetic disorders | None | View |
| Congenital Tricuspid Valve Incompetence | SYSTEMATIC_ASSESSMENT | Congenital, familial and genetic disorders | None | View |
| Laryngomalacia | SYSTEMATIC_ASSESSMENT | Congenital, familial and genetic disorders | None | View |
| Patent Ductus Arteriosus | SYSTEMATIC_ASSESSMENT | Congenital, familial and genetic disorders | None | View |
| Persistent Fetal Circulation | SYSTEMATIC_ASSESSMENT | Congenital, familial and genetic disorders | None | View |
| Trisomy 21 | SYSTEMATIC_ASSESSMENT | Congenital, familial and genetic disorders | None | View |
| Ventricular Septal Defect | SYSTEMATIC_ASSESSMENT | Congenital, familial and genetic disorders | None | View |
| Cellulitis | SYSTEMATIC_ASSESSMENT | Infections and infestations | None | View |
| Sepsis | SYSTEMATIC_ASSESSMENT | Infections and infestations | None | View |
| Intentional Overdose | SYSTEMATIC_ASSESSMENT | Injury, poisoning and procedural complications | None | View |
| Glioblastoma | SYSTEMATIC_ASSESSMENT | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | None | View |
| Squamous Cell Carcinoma of the Oral Cavity | SYSTEMATIC_ASSESSMENT | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | None | View |
| Cerebral Ventricle Dilatation | SYSTEMATIC_ASSESSMENT | Nervous system disorders | None | View |
| Failure to Thrive | SYSTEMATIC_ASSESSMENT | Pregnancy, puerperium and perinatal conditions | None | View |
| Suicide Attempt | SYSTEMATIC_ASSESSMENT | Psychiatric disorders | None | View |
| Anxiety | SYSTEMATIC_ASSESSMENT | Psychiatric disorders | None | View |
| Acute Kidney Injury | SYSTEMATIC_ASSESSMENT | Renal and urinary disorders | None | View |
| Neonatal Respiratory Failure | SYSTEMATIC_ASSESSMENT | Respiratory, thoracic and mediastinal disorders | None | View |
| Transient Tachypnoea of the Newborn | SYSTEMATIC_ASSESSMENT | Respiratory, thoracic and mediastinal disorders | None | View |
| Pulmonary Embolism | SYSTEMATIC_ASSESSMENT | Respiratory, thoracic and mediastinal disorders | None | View |
| Eventration Repair | SYSTEMATIC_ASSESSMENT | Surgical and medical procedures | None | View |
| Deep Vein Thrombosis | SYSTEMATIC_ASSESSMENT | Vascular disorders | None | View |
| Acute Coronary syndrome | SYSTEMATIC_ASSESSMENT | Cardiac disorders | None | View |
| Bifascicular Block | SYSTEMATIC_ASSESSMENT | Cardiac disorders | None | View |
| Appendicitis Noninfective | SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | None | View |
| Subileus | SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | None | View |
| Death | SYSTEMATIC_ASSESSMENT | General disorders | None | View |
| Chest Pain | SYSTEMATIC_ASSESSMENT | General disorders | None | View |
| Infusion Site Thrombosis | SYSTEMATIC_ASSESSMENT | General disorders | None | View |
| Wound Infection Bacterial | SYSTEMATIC_ASSESSMENT | Infections and infestations | None | View |
| Diverticulitis | SYSTEMATIC_ASSESSMENT | Infections and infestations | None | View |
| Osteomyelitis | SYSTEMATIC_ASSESSMENT | Infections and infestations | None | View |
| Urosepsis | SYSTEMATIC_ASSESSMENT | Infections and infestations | None | View |
| Clostridium Difficile Infection | SYSTEMATIC_ASSESSMENT | Infections and infestations | None | View |
| Septic Shock | SYSTEMATIC_ASSESSMENT | Infections and infestations | None | View |
| Thermal Burn | SYSTEMATIC_ASSESSMENT | Injury, poisoning and procedural complications | None | View |
| Graft Loss | SYSTEMATIC_ASSESSMENT | Injury, poisoning and procedural complications | None | View |
| Diabetic Metabolic Decompensation | SYSTEMATIC_ASSESSMENT | Metabolism and nutrition disorders | None | View |
| Basal Cell Carcinoma | SYSTEMATIC_ASSESSMENT | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | None | View |
| Seizure | SYSTEMATIC_ASSESSMENT | Nervous system disorders | None | View |
| Acute Respiratory Failure | SYSTEMATIC_ASSESSMENT | Respiratory, thoracic and mediastinal disorders | None | View |
| Acute Respiratory Distress Syndrome | SYSTEMATIC_ASSESSMENT | Respiratory, thoracic and mediastinal disorders | None | View |
| Internal Fixation of Fracture | SYSTEMATIC_ASSESSMENT | Surgical and medical procedures | None | View |
| Therapeutic Procedure | SYSTEMATIC_ASSESSMENT | Surgical and medical procedures | None | View |
| Cholecystectomy | SYSTEMATIC_ASSESSMENT | Surgical and medical procedures | None | View |
| Phlebitis Superficial | SYSTEMATIC_ASSESSMENT | Vascular disorders | None | View |
| Term | Type | Organ System | Vocab | View |
|---|---|---|---|---|
| Leukocytosis | SYSTEMATIC_ASSESSMENT | Blood and lymphatic system disorders | None | View |
| Nausea | SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | None | View |
| Vomiting | SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | None | View |
| Constipation | SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | None | View |
| Pyrexia | SYSTEMATIC_ASSESSMENT | General disorders | None | View |
| Urinary Tract Infection | SYSTEMATIC_ASSESSMENT | Infections and infestations | None | View |
| Wound Infection Bacterial | SYSTEMATIC_ASSESSMENT | Infections and infestations | None | View |
| Sepsis | SYSTEMATIC_ASSESSMENT | Infections and infestations | None | View |
| Sinusitus | SYSTEMATIC_ASSESSMENT | Infections and infestations | None | View |
| Graft Loss | SYSTEMATIC_ASSESSMENT | Injury, poisoning and procedural complications | None | View |
| Joint Range of Motion Decreased | SYSTEMATIC_ASSESSMENT | Musculoskeletal and connective tissue disorders | None | View |
| Pain in Extremity | SYSTEMATIC_ASSESSMENT | Musculoskeletal and connective tissue disorders | None | View |
| Insomnia | SYSTEMATIC_ASSESSMENT | Psychiatric disorders | None | View |
| Pruritis | SYSTEMATIC_ASSESSMENT | Skin and subcutaneous tissue disorders | None | View |
| Rash | SYSTEMATIC_ASSESSMENT | Skin and subcutaneous tissue disorders | None | View |
| Lymphocyte Count Decreased | SYSTEMATIC_ASSESSMENT | Investigations | None | View |
| Tachycardia | SYSTEMATIC_ASSESSMENT | Cardiac disorders | None | View |
| Pain | SYSTEMATIC_ASSESSMENT | General disorders | None | View |
| Wound Complications | SYSTEMATIC_ASSESSMENT | Injury, poisoning and procedural complications | None | View |
| Headache | SYSTEMATIC_ASSESSMENT | Nervous system disorders | None | View |